Non-stimulant Strattera More Widely Available for Attention- Deficit/Hyperactivity Disorder in Children and Adolescents (PR Newswire via Yahoo! Finance)

home   >   yahoo news

Eli Lilly and Company's Strattera® , the only approved non-stimulant medication proven clinically effective at treating the symptoms of attention- deficit/hyperactivity disorder , is now more widely available in Europe, following marketing authorizations granted by regulatory authorities in Germany, The Netherlands and Norway.

- link to Non-stimulant Strattera More Widely Available for Attention- Deficit/Hyperactivity Disorder in Children and Adolescents (PR Newswire via Yahoo! Finance) -
Last update: 06/01/2005

Recommended Reading

    Borrowed Light
    The Ultimate Cause and Preventive Cure for the Common Cold: How to Prevent Yourself from Catching the Common Cold or the Flu
    Know when to use rapid influenza tests: unnecessary during peak periods.(Infectious Diseases) : An article from: Pediatric News
    Act of God
    Politically Correct Death: Answering the Arguments for Abortion Rights
    Three Approaches to Abortion: A Thoughtful and Compassionate Guide to Today's Most Controversial Issue
    Sex and Consequences : Abortion, Public Policy, and the Economics of Fertility
    Achy-breaky: I am getting headaches almost every day. I take ibuprofen, but it seems like they get worse. Why?(Body: Q&A) : An article from: Girls' Life